Northern 2 VCT PLC
Introduction
Northern 2 VCT PLC is a Venture Capital Trust established under the legislation introduced in the Finance Act 1995. The fund is a member of the Association of Investment Companies.
The London Stock Exchange code is NTV.L
If you would like to receive a copy of the latest annual and half-yearly reports, by post, please contact us. If you would like to download reports in PDF format, please view the ‘Reports and Shareholder Circulars’ section below.
Chair statement
“We are pleased to report an overall increase in the holding value of the unquoted portfolio, with strong performances from a number of portfolio companies.”
- Thomas Chambers
Investor area
| Launch date | 1999 |
|---|---|
| Share price | 54.50p |
| Share price total return (10 years) | 172.2 |
| Latest NAV per share | 58.2p (30 June 2025) |
| NAV total return over 10 years | 167.6 |
| No of shares in issue | 239,707,349 |
| Dividend yield | 5.5% |
“Share price” is mid-market price as at 17 November 2025. “Dividend yield” is based on dividends paid and proposed in respect of latest full financial year, excluding special dividends, expressed as a percentage of share price. Total return statistics are for periods to 17 November 2025, return shown is on £100 invested, based on mid to mid share price/latest published NAV, assuming net income re-invested (source: Morningstar). In accordance with AIC methodology, figures shown over 5 years are based on NAVs excluding current period revenue.
Naitive | Transforming musculoskeletal care with AI
Naitive Technologies is a population health company developing AI-enabled clinical pathways to transform patient care. They have pioneered a new approach to chronic disease care - one that is based on existing clinical data, digital interventions, and scalable computational capabilities, all built on a single integrated architecture.
Watch as Founder & CEO, Dr will Briggs, CIO, Dr Tom Beale and COO, Dr Cat Kelly explain its 'Osteosight' technology and the future impact they are hoping it will have on early detection of osteoporosis and osteopenia.
Marketing of shares to retail investors
We confirm that the shares of Northern 2 VCT are currently ‘excluded securities’ in accordance with guidance issued by the Financial Conduct Authority and can therefore be recommended to retail investors by financial advisers.
Advisers
| Registrars | The City Partnership (UK) Limited |
|---|---|
| Stockbroker | Panmure Gordon (UK) Limited |
| Auditors | Johnston Carmichael LLP |
Notes
An investment in a Venture Capital Trust (“VCT”) carries a higher risk than many other forms of investment. In addition, the value of an investment in a VCT may go down as well as up and investors may not get back the full amount invested, even after taking into account the tax reliefs. VCTs usually trade at a discount to their net asset value. It may be difficult to exit VCTs and they should be considered as long-term investments. The past performance of the Company is not a reliable indicator of its future performance.
Mercia does not offer investment or tax advice or make recommendations regarding investments and investors will not be treated as clients of Mercia.